The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 (anti-PD-L1 ADC) in patients with advanced/metastatic solid tumors.
 
Jie Wang
No Relationships to Disclose
 
Rui Wan
No Relationships to Disclose
 
Shan Zeng
No Relationships to Disclose
 
Lin Wu
No Relationships to Disclose
 
Hua Zhong
No Relationships to Disclose
 
Jingxun Wu
No Relationships to Disclose
 
Guowu Wu
No Relationships to Disclose
 
Jianchun Duan
No Relationships to Disclose
 
Shuqing Wei
No Relationships to Disclose
 
Zhiye Zhang
No Relationships to Disclose
 
Linlin Wang
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose
 
Jingfeng Liu
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Xinjing Wang
Employment - Shanghai Henlius Biotech
 
Xiaoli Hou
Employment - Shanghai Henlius Biotech
 
Qingyu Wang
Employment - Shanghai Henlius Biotech
 
Haoyu Yu
Employment - Shanghai Henlius Biotech
 
Jing Li
Employment - Shanghai Henlius Biotech